Figure 7.
Model of IL-1–mediated inflammaging as a driver of Tet2+/−clonal hematopoiesis. Working model on positive feedback loop driving development of aberrant Tet2+/− hematopoiesis induced by inflammaging-derived IL-1. Increased IL-1 levels derived from aged Tet2+/− mature myeloid cells act directly on HSPCs favoring Tet2+/− HSPC expansion (circular arrows), repopulation capacity, and multilineage differentiation (linear arrows) over WT HSPCs. IL-1–mediated Tet2+/− clonal expansion can be modulated by the administration of IL-1R1 antagonist (anakinra). See Discussion for detailed explanation.